Literature DB >> 29222254

Chronic neutropenia in LGL leukemia and rheumatoid arthritis.

Tal Gazitt1, Thomas P Loughran2.   

Abstract

This section reviews the diagnostic criteria and pathogenesis of large granular lymphocyte (LGL) leukemia. There is a particular focus on the overlap of LGL leukemia and rheumatoid arthritis (Felty's syndrome). Current understanding of the mechanisms of neutropenia in these disorders is discussed. Finally, treatment indications and therapeutic recommendations are outlined.
© 2016 by The American Society of Hematology. All rights reserved.

Entities:  

Mesh：

Year:  2017        PMID： 29222254      PMCID： PMC6142558          DOI： 10.1182/asheducation-2017.1.181

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN： 1520-4383


  44 in total

Review 1.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

2.  How I treat LGL leukemia.

Authors:  Thierry Lamy; Thomas P Loughran
Journal:  Blood       Date:  2010-12-29       Impact factor: 22.113

3.  Constitutive production of proinflammatory cytokines RANTES, MIP-1beta and IL-18 characterizes LGL leukemia.

Authors:  Ravi Kothapalli; Susan B Nyland; Irina Kusmartseva; Ratna D Bailey; Tylee M McKeown; Thomas P Loughran
Journal:  Int J Oncol       Date:  2005-02       Impact factor: 5.650

4.  Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia.

Authors:  Hanna L M Rajala; Samuli Eldfors; Heikki Kuusanmäki; Arjan J van Adrichem; Thomas Olson; Sonja Lagström; Emma I Andersson; Andres Jerez; Michael J Clemente; Yiyi Yan; Dan Zhang; Andy Awwad; Pekka Ellonen; Olli Kallioniemi; Krister Wennerberg; Kimmo Porkka; Jaroslaw P Maciejewski; Thomas P Loughran; Caroline Heckman; Satu Mustjoki
Journal:  Blood       Date:  2013-04-17       Impact factor: 22.113

5.  Local Joint inflammation and histone citrullination in a murine model of the transition from preclinical autoimmunity to inflammatory arthritis.

Authors:  Dong Hyun Sohn; Christopher Rhodes; Kazuhiro Onuma; Xiaoyan Zhao; Orr Sharpe; Tal Gazitt; Rani Shiao; Justyna Fert-Bober; Danye Cheng; Lauren J Lahey; Heidi H Wong; Jennifer Van Eyk; William H Robinson; Jeremy Sokolove
Journal:  Arthritis Rheumatol       Date:  2015-11       Impact factor: 10.995

6.  Immune complexes and the pathogenesis of neutropenia in Felty's syndrome.

Authors:  F C Breedveld; G J Lafeber; E de Vries; J H van Krieken; A Cats
Journal:  Ann Rheum Dis       Date:  1986-08       Impact factor: 19.103

7.  Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia.

Authors:  J P Maciejewski; C Selleri; T Sato; S Anderson; N S Young
Journal:  Br J Haematol       Date:  1995-09       Impact factor: 6.998

8.  Impaired granulocytopoiesis in patients with chronic idiopathic neutropenia is associated with increased apoptosis of bone marrow myeloid progenitor cells.

Authors:  Helen A Papadaki; Aristides G Eliopoulos; Theodoros Kosteas; Claudia Gemetzi; Athina Damianaki; Helen Koutala; Juergen Bux; George D Eliopoulos
Journal:  Blood       Date:  2002-11-27       Impact factor: 22.113

9.  Deep sequencing of the T-cell receptor repertoire in CD8+ T-large granular lymphocyte leukemia identifies signature landscapes.

Authors:  Michael J Clemente; Bartlomiej Przychodzen; Andres Jerez; Brittney E Dienes; Manuel G Afable; Holleh Husseinzadeh; Hanna L M Rajala; Marcin W Wlodarski; Satu Mustjoki; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2013-10-22       Impact factor: 22.113

10.  Immunosuppressive therapy of LGL leukemia: prospective multicenter phase II study by the Eastern Cooperative Oncology Group (E5998).

Authors:  T P Loughran; L Zickl; T L Olson; V Wang; D Zhang; H L M Rajala; Z Hasanali; J M Bennett; H M Lazarus; M R Litzow; A M Evens; S Mustjoki; M S Tallman
Journal:  Leukemia       Date:  2014-09-13       Impact factor: 11.528
View more
  10 in total

Review 1.  Pathogenesis and Treatment of T-Large Granular Lymphocytic Leukemia (T-LGLL) in the Setting of Rheumatic Disease.

Authors:  Nina Couette; Wael Jarjour; Jonathan E Brammer; Alexa Simon Meara
Journal:  Front Oncol       Date:  2022-06-07       Impact factor: 5.738

2.  Large granular lymphocytic leukemia cured by allogeneic stem cell transplant: a case report.

Authors:  Edward Carey; Nicholas Ward; Maher Abdul-Hay
Journal:  J Med Case Rep       Date:  2022-06-08

Review 3.  Intersection Between Large Granular Lymphocyte Leukemia and Rheumatoid Arthritis.

Authors:  Katharine B Moosic; Kusuma Ananth; Felipe Andrade; David J Feith; Erika Darrah; Thomas P Loughran
Journal:  Front Oncol       Date:  2022-05-13       Impact factor: 5.738

Review 4.  Genomics of LGL leukemia and select other rare leukemia/lymphomas.

Authors:  Katharine B Moosic; Umadevi Paila; Kristine C Olson; Karolina Dziewulska; T Tiffany Wang; Jeffrey C Xing; Aakrosh Ratan; David J Feith; Thomas P Loughran; Thomas L Olson
Journal:  Best Pract Res Clin Haematol       Date:  2019-06-06       Impact factor: 3.020

5.  The non-leukemic T cell large granular lymphocytic leukemia variant with marked splenomegaly and neutropenia in the setting of rheumatoid arthritis - Felty syndrome and hepatosplenic T cell lymphoma mask.

Authors:  Vadim Gorodetskiy; Natalya Probatova; Yulia Sidorova; Natalia Kupryshina; Tatiana Obukhova; Vladimir Vasilyev; Natalya Ryzhikova; Andrey Sudarikov
Journal:  Am J Blood Res       Date:  2021-06-15

6.  Immunodeficiency and bone marrow failure with mosaic and germline TLR8 gain of function.

Authors:  Jahnavi Aluri; Alicia Bach; Saara Kaviany; Luana Chiquetto Paracatu; Maleewan Kitcharoensakkul; Magdalena A Walkiewicz; Christopher D Putnam; Marwan Shinawi; Nermina Saucier; Elise M Rizzi; Michael T Harmon; Molly P Keppel; Michelle Ritter; Morgan Similuk; Elaine Kulm; Michael Joyce; Adriana A de Jesus; Raphaela Goldbach-Mansky; Yi-Shan Lee; Marina Cella; Peggy L Kendall; Mary C Dinauer; Jeffrey J Bednarski; Christina Bemrich-Stolz; Scott W Canna; Shirley M Abraham; Matthew M Demczko; Jonathan Powell; Stacie M Jones; Amy M Scurlock; Suk See De Ravin; Jack J Bleesing; James A Connelly; V Koneti Rao; Laura G Schuettpelz; Megan A Cooper
Journal:  Blood       Date:  2021-05-06       Impact factor: 25.476

7.  Outcomes for patients with severe chronic neutropenia treated with granulocyte colony-stimulating factor.

Authors:  David C Dale; Audrey Anna Bolyard; James A Shannon; James A Connelly; Daniel C Link; Mary Ann Bonilla; Peter E Newburger
Journal:  Blood Adv       Date:  2022-07-12

8.  Large granular lymphocyte leukemia serum and corresponding hematological parameters reveal unique cytokine and sphingolipid biomarkers and associations with STAT3 mutations.

Authors:  Kristine C Olson; Katharine B Moosic; Marieke K Jones; Paige M K Larkin; Thomas L Olson; Mariella F Toro; Todd E Fox; David J Feith; Thomas P Loughran
Journal:  Cancer Med       Date:  2020-07-25       Impact factor: 4.452

Review 9.  Neutropenia and Large Granular Lymphocyte Leukemia: From Pathogenesis to Therapeutic Options.

Authors:  Giulia Calabretto; Antonella Teramo; Gregorio Barilà; Cristina Vicenzetto; Vanessa Rebecca Gasparini; Gianpietro Semenzato; Renato Zambello
Journal:  Cells       Date:  2021-10-19       Impact factor: 6.600

10.  Autoimmune polyendocrine syndrome type 1: an Italian survey on 158 patients.

Authors:  S Garelli; M Dalla Costa; C Sabbadin; S Barollo; B Rubin; R Scarpa; S Masiero; A Fierabracci; C Bizzarri; A Crinò; M Cappa; M Valenzise; A Meloni; A M De Bellis; C Giordano; F Presotto; R Perniola; D Capalbo; M C Salerno; A Stigliano; G Radetti; V Camozzi; N A Greggio; F Bogazzi; I Chiodini; U Pagotto; S K Black; S Chen; B Rees Smith; J Furmaniak; G Weber; F Pigliaru; L De Sanctis; C Scaroni; C Betterle
Journal:  J Endocrinol Invest       Date:  2021-05-18       Impact factor: 4.256
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.